CIK 0001527352 · <br>Emerging growth company
Nexalin Technology, Inc.
Sign in to watch- Ticker
- NXL
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 275566468
- Phone
- (832) 260-0222
- Business address
- 1776 YORKTOWN, SUITE 550, HOUSTON, TX, 77056
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-19 | White Mark CEO | Grant or award · Stock Option (right to buy)* | +1,000,000 | 2,387,024 | ||
| 2025-12-19 | Van Fleet Justin CFO | Grant or award · Stock Option (right to buy)* | +100,000 | 230,435 | ||
| 2025-12-19 | Owens David Chief Medical Officer | Grant or award · Stock Option (right to buy)* | +1,000,000 | 2,484,809 | ||
| 2025-12-19 | Shelton Carolyn Hamby Sr. VP - Quality - Regulatory | Grant or award · Stock Option (right to buy)* | +100,000 | 210,620 | ||
| 2025-12-19 | Hu Ben Director | Grant or award · Stock Option (right to buy)* | +100,000 | 100,000 | ||
| 2025-12-19 | Kazden Alan Director | Grant or award · Stock Option (right to buy)* | +100,000 | 362,500 | ||
| 2025-09-29 | OSSER LEONARD 10% owner | Grant or award | +83,333 | 1,618,577 | ||
| 2025-09-29 | Owens David Chief Medical Officer | Grant or award | +36,459 | 191,252 | ||
| 2025-09-29 | Hu Ben Director | Grant or award | +36,459 | 377,095 | ||
| 2025-09-29 | Kazden Alan Director | Grant or award | +36,459 | 119,590 | ||
| 2025-09-12 | Shelton Carolyn Hamby Sr. VP - Quality - Regulatory | Grant or award · Stock Option (right to buy) | +20,000 | 110,620 | ||
| 2025-09-12 | Owens David Chief Medical Officer | Grant or award · Stock Option (right to buy) | +203,125 | 1,384,809 | ||
| 2025-09-12 | Owens David Chief Medical Officer | Grant or award · Stock Option (right to buy) | +100,000 | 1,484,809 | ||
| 2025-09-10 | Elson Marilyn 10% owner | Sale · Common Stock Warrants | −23,150 | $0.02 | $403 | 112,850 |
| 2025-07-17 | Elson Marilyn 10% owner | Grant or award · Stock Option (right to buy) | +150,000 | 286,000 | ||
| 2025-07-17 | Elson Marilyn 10% owner | Grant or award · Stock Option (right to buy) | +30,000 | 316,000 | ||
| 2025-07-17 | Elson Marilyn 10% owner | Grant or award · Stock Option (right to buy) | +30,000 | 346,000 | ||
| 2025-07-17 | Elson Marilyn 10% owner | Grant or award · Stock Option (right to buy) | +30,000 | 376,000 | ||
| 2025-07-17 | Elson Marilyn 10% owner | Grant or award · Stock Option (right to buy) | +30,000 | 406,000 | ||
| 2025-07-17 | Elson Marilyn 10% owner | Grant or award · Stock Option (right to buy) | +30,000 | 436,000 |
Page 1 of 3 · 57 trades